D S Anson

2.1k total citations
35 papers, 1.8k citations indexed

About

D S Anson is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, D S Anson has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Genetics and 12 papers in Physiology. Recurrent topics in D S Anson's work include Virus-based gene therapy research (16 papers), Lysosomal Storage Disorders Research (12 papers) and RNA Interference and Gene Delivery (7 papers). D S Anson is often cited by papers focused on Virus-based gene therapy research (16 papers), Lysosomal Storage Disorders Research (12 papers) and RNA Interference and Gene Delivery (7 papers). D S Anson collaborates with scholars based in Australia, United Kingdom and United States. D S Anson's co-authors include John J. Hopwood, Julie Bielicki, G.G. Brownlee, C. Phillip Morris, F. Giannelli, K.H. Andy Choo, Peter R. Clements, Peter J. Wilson, Peter R. Winship and Joyce A. Huddleston and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

D S Anson

35 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D S Anson Australia 23 875 698 445 419 330 35 1.8k
Emilie H. Mules United States 19 825 0.9× 337 0.5× 135 0.3× 239 0.6× 129 0.4× 29 1.6k
Elizabeth A. Eklund United States 33 1.6k 1.8× 157 0.2× 579 1.3× 158 0.4× 119 0.4× 90 2.7k
Elena L. Aronovich United States 19 618 0.7× 388 0.6× 32 0.1× 389 0.9× 222 0.7× 38 1.0k
Lynne Lacomis United States 15 1.6k 1.9× 205 0.3× 170 0.4× 89 0.2× 100 0.3× 17 2.4k
M B Prystowsky United States 15 681 0.8× 174 0.2× 201 0.5× 125 0.3× 88 0.3× 28 1.7k
Hung Do United States 12 694 0.8× 285 0.4× 89 0.2× 217 0.5× 101 0.3× 25 1.1k
Peter N. Graves United States 24 686 0.8× 251 0.4× 39 0.1× 327 0.8× 183 0.6× 42 1.7k
Stefan Glaser Australia 23 1.9k 2.2× 67 0.1× 465 1.0× 254 0.6× 95 0.3× 34 2.6k
T Kojima Japan 8 962 1.1× 111 0.2× 157 0.4× 214 0.5× 98 0.3× 12 1.8k
Ali A. Zarrin United States 20 1.3k 1.5× 217 0.3× 71 0.2× 148 0.4× 198 0.6× 30 2.4k

Countries citing papers authored by D S Anson

Since Specialization
Citations

This map shows the geographic impact of D S Anson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D S Anson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D S Anson more than expected).

Fields of papers citing papers by D S Anson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D S Anson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D S Anson. The network helps show where D S Anson may publish in the future.

Co-authorship network of co-authors of D S Anson

This figure shows the co-authorship network connecting the top 25 collaborators of D S Anson. A scholar is included among the top collaborators of D S Anson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D S Anson. D S Anson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macsai, Carmen E., Ainslie L.K. Derrick‐Roberts, Xiaodan Ding, et al.. (2012). Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII. Molecular Genetics and Metabolism. 106(2). 202–213. 28 indexed citations
2.
Liu, Chuanhe, et al.. (2010). Lentiviral airway gene transfer in lungs of mice and sheep: successes and challenges. The Journal of Gene Medicine. 12(8). 647–658. 15 indexed citations
3.
Cmielewski, Patricia, D S Anson, & David Parsons. (2010). Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length. Respiratory Research. 11(1). 84–84. 44 indexed citations
4.
Kaufmann, C., Helen M. Brereton, D S Anson, et al.. (2007). Lentivirus-mediated gene transfer to the rat, ovine and human cornea. Gene Therapy. 14(9). 760–767. 31 indexed citations
5.
Koldej, Rachel, et al.. (2005). Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. The Journal of Gene Medicine. 7(11). 1390–1399. 41 indexed citations
6.
Anson, D S & Kylie R. Dunning. (2005). Codon-Optimized Reading Frames Facilitate High-Level Expression of the HIV-1 Minor Proteins. Molecular Biotechnology. 31(1). 85–88. 6 indexed citations
7.
Fuller, Maria & D S Anson. (2004). Can the Use of HIV-1 Derived Gene Transfer Vectors for Clinical Application be Justified?. Current Gene Therapy. 4(1). 65–77. 5 indexed citations
8.
Anson, D S & Maria P. Limberis. (2004). An improved β-galactosidase reporter gene. Journal of Biotechnology. 108(1). 17–30. 18 indexed citations
9.
Anson, D S & Maria Fuller. (2003). Rational development of a HIV‐1 gene therapy vector. The Journal of Gene Medicine. 5(10). 829–838. 31 indexed citations
10.
Fuller, Maria & D S Anson. (2001). Helper Plasmids for Production of HIV-1-Derived Vectors. Human Gene Therapy. 12(17). 2081–2093. 22 indexed citations
11.
12.
Occhiodoro, Teresa, Maria Fuller, Wayne J. Hawthorne, et al.. (1997). Canine fucosidosis: a model for retroviral gene transfer into haematopoietic stem cells. Neuromuscular Disorders. 7(5). 361–366. 15 indexed citations
13.
Bielicki, Julie, John J. Hopwood, & D S Anson. (1996). Correction of Sanfilippo A Skin Fibroblasts by Retroviral Vector-Mediated Gene Transfer. Human Gene Therapy. 7(16). 1965–1970. 18 indexed citations
14.
Occhiodoro, Teresa & D S Anson. (1996). Isolation of the canine α-L-fucosidase cDNA and definition of the fucosidosis mutation in English Springer Spaniels. Mammalian Genome. 7(4). 271–274. 14 indexed citations
15.
Anson, D S, Volker Müller, Julie Bielicki, G. S. Harper, & John J. Hopwood. (1993). Overexpression of N-acetylgalactosamine-4-sulphatase induces a multiple sulphatase deficiency in mucopolysaccharidosis-type-VI fibroblasts. Biochemical Journal. 294(3). 657–662. 23 indexed citations
16.
Anson, D S, Julie Bielicki, & John J. Hopwood. (1992). Correction of Mucopolysaccharidosis Type I Fibroblasts by Retroviral-Mediated Transfer of the Human α- l -Iduronidase Gene. Human Gene Therapy. 3(4). 371–379. 34 indexed citations
17.
Scott, Hamish S., D S Anson, Paul V. Nelson, et al.. (1991). Human alpha-L-iduronidase: cDNA isolation and expression.. Proceedings of the National Academy of Sciences. 88(21). 9695–9699. 125 indexed citations
18.
Matthews, R. James, I R Peake, A L Bloom, & D S Anson. (1988). Carrier detection through the use of abnormal deletion junction fragments in a case of haemophilia B involving complete deletion of the factor IX gene.. Journal of Medical Genetics. 25(11). 779–780. 1 indexed citations
19.
Anson, D S, Derek J. Blake, Peter R. Winship, Daniel Birnbaum, & G.G. Brownlee. (1988). Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients.. The EMBO Journal. 7(9). 2795–2799. 21 indexed citations
20.
Winship, Peter R., D S Anson, C. R. Rizza, & George G. Brownlee. (1984). Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Research. 12(23). 8861–8872. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilie H. Mules Breakdown of academic impact, for papers by Elizabeth A. Eklund Breakdown of academic impact, for papers by Elena L. Aronovich Breakdown of academic impact, for papers by Lynne Lacomis Breakdown of academic impact, for papers by M B Prystowsky Breakdown of academic impact, for papers by Hung Do Breakdown of academic impact, for papers by Peter N. Graves Breakdown of academic impact, for papers by Stefan Glaser Breakdown of academic impact, for papers by T Kojima Breakdown of academic impact, for papers by Ali A. Zarrin
Rankless by CCL
2026